Recently, the overseas team of Weihe Biotech has been busy, traveling to Kuala Lumpur, Malaysia, to conduct in-depth visits to key customers in the fields of transplantation and blood transfusion
2025-07-21
The 2025 Guangdong Province Clinical Blood Transfusion Advanced Training Course has successfully concluded at Guangzhou Medical University, and Weihe Biotechnology is honored to participate and provid
2025-06-30
On the occasion of World Blood Donation Day in 2025, Weihe Biotechnology wishes every blood donor well. At the same time, it also contributes to the blood transfusion industry through continuous techn
2025-06-14
When Bibo in Xin anjiang meets the pride of Mount Huangshan Pine, and when the Anhui style ancient charm collision team is enthusiastic, the 2025 group building activity of Jiangsu Weihe Biotechnology
2025-04-22
Any genetic polymorphism that can be detected in the blood can be referred to as blood type, but blood type is usually limited to the polymorphism of blood cell surface antigens, including red blood c
2025-04-02
The 22nd China International Laboratory Medicine and Blood Transfusion Instrument Reagent Expo (CACLP) and the 5th China International IVD Upstream Raw Materials and Supply Chain Expo (CISCE) will be
2025-03-19
Pregnancy is the happiest moment for every family, but some potential health risks may cast a shadow over this happiness.
2025-03-08
At a time when the global biopharmaceutical industry is undergoing changes, the industry is also looking forward to the biopharmaceutical industry moving towards a more fair, healthy, and stable marke
2025-02-17
In the context of industry restructuring, market downturn, and unstable business factors, Weihe Biotechnology still achieved a 50% increase in revenue and doubled profits for the whole year of 2024. W
2025-01-29
The Weihe booth showcased our innovative achievements in the field of transplantation and blood transfusion through a series of products such as human leukocyte (HLA), platelet (HPA), and red blood ce
2024-07-16